Country and Site Feasibility

TrialHub's Country and Site Feasibility module is a data platform designed to support feasibility experts, CROs, pharma companies, and biotechs in selecting the most appropriate countries and clinical sites for their trials. It consolidates country-level and site-level insights into a single interface accessible to all team members, covering epidemiology, competition, past experience, recruitment rates, and startup timelines.

The platform is built around the feasibility workflow, guiding users from initial country assessment through to site and investigator identification. Users begin by applying filters across a range of parameters, then progress through structured analytical steps to build a data-backed trial strategy.

Filter and Search Capabilities

• Filter by indications, countries, trial status, and trial details.
• Apply advanced filters including keywords, biomarkers, timelines, purpose and treatments, drug categories, eligibility criteria, and decentralized trial parameters.

Country-Level Assessment

• Assess countries at a glance across five dimensions: prevalence, competition, past experience, recruitment rate, and startup timelines.
• Estimate the potential number of patients who need a given treatment in each country under consideration using epidemiology data.
• Identify countries with the highest number of competing trials in a given indication and monitor the landscape for new trials that may recruit from the same patient pool.
• Evaluate a country's capacity by reviewing its historical experience in the relevant indication, or identify research-native regions to address unmet patient needs.
• Access historic recruitment rate benchmarks by country to support recruitment projections and identify new countries that could accelerate enrollment.
• Plan country rollout using startup timeline data.

Trial Performance Benchmarking

• Compare planned versus actual trial performance across metrics including recruitment rate, number of sites and countries, enrolled patients, and recruitment duration.
• Create realistic benchmarks to estimate trial budgets and duration.
• Analyse under- and overperforming trials to identify patterns and discover sites that exceeded expectations.

Site and Investigator Identification

• Identify sites with proven experience in a specific indication.
• View which sites are actively running trials.
• Find sites with a larger nearby patient population.
• Search for investigators with experience in the relevant indication.
• Access detailed investigator profiles with up-to-date contact information.
• Build curated lists of potential site and investigator partners for a study.

Use Cases by Organisation Type

• Pharma: Supports avoidance of costly protocol amendments, early identification of recruitment challenges, and development of protocols grounded in real-world data.
• CRO: Enables faster proposal creation, trial strategy design, and ongoing monitoring of the standard of care landscape to anticipate recruitment delays.
• Biotech: Supports product validation, study strategy selection, and risk mitigation through monitoring of the clinical landscape.

Support and Customer Service

• Includes an "Ask the Analyst" feature providing access to a dedicated team of medical experts, analysts, and data scientists.
• Human customer support is available throughout the user journey, including proactive outreach when searches do not return expected results.
• Product development is guided by user feedback and evolving customer needs.

TrialHub is used by pharma companies, CROs, and biotechs of varying sizes. Reported outcomes from users include a 25% reduction in time spent on country feasibility (Avance Clinical) and a site response rate exceeding 85% with over 50% positive participation interest — more than three times the industry standard of 30% (Confidence Research).